Handok Inc banner

Handok Inc
KRX:002390

Watchlist Manager
Handok Inc Logo
Handok Inc
KRX:002390
Watchlist
Price: 11 750 KRW 0.17% Market Closed
Market Cap: ₩161.7B

Handok Inc
Investor Relations

Handok, Inc. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The firm's products include Amaryl for diabetes; Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular diseases; Teveten and Triapin for essential hypertension; Munobal for hypertension and stenocardia; Ketas for disturbance of cerebral circulation; Lasix for hypertension and edema, and remedies for skin and others. The company also provides over-the-counter (OTC) pharmaceuticals, healthcare products, as well as medical devices, diagnostic reagents and vaccines. In addition, the Company is involved in the real estates rental business. On July 26, 2013, it changed its name to HANDOK Inc. from Handok Pharmaceuticals Co., LTD.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Young-Jin Kim M.B.A.
Chairman & CEO
No Bio Available
Ms. Jeong-yol Cho
President
No Bio Available
Ms. MIYEON KIM
President, Director & COO
No Bio Available
Jin Ki Baek
Vice President & Executive Director
No Bio Available

Contacts

Address
SEOUL
Seoul
132, Teheran-ro, Gangnam-gu
Contacts
+8225275114
www.handok.co.kr
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett